Morgan Stanley PE Asia completed the acquisition of a majority stake in ClearMedi Healthcare for $35m.

Morgan Stanley PE Asia, a private equity investor, completed the acquisition of a majority stake in ClearMedi Healthcare, a radiology and nuclear medicine services provider, for $35m. “Morgan Stanley’s entry into the Indian healthcare sector signifies a transformative moment for our industry. As we continue to expand and provide high-quality healthcare solutions to our patients, Commander Navneet Bali’s visionary leadership, coupled with Morgan Stanley’s support, will play a pivotal role in shaping our company’s future,” Shashi Kant Baliyan, ClearMedi Healthcare Founder.